Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: Prognostic significance and comparison with p53 and bcl-2

Acta Histochemica

Volumn 102, Issue 3, 2000, Pages 323-338

  Nguyen, Viet Nhung ^a   Miejovský, Pavel ^a   Miejovsky Toma ^a   Melínová, Libue ^a   Mandys, Václav ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

bcl 2; Cyclin D1; Histopathology; Immunohistochemistry; Ki 67; Lung carcinoma; p53; PCNA

Indexed keywords

CYCLIN D1; CYCLINE; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; TUMOR MARKER;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MALE; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

EID: 0033843716     PISSN: 00651281     EISSN: None     Source Type: Journal    
DOI: 10.1078/S0065-1281(04)70039-2     Document Type: Article

References (48)

1. Study of the expression of proliferating cell nuclear antigen and p185 in non-small cell lung carcinoma
2. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer
3. Regulation of p53 stability
4. p53 and bcl-2 Protein expression in non-small-cell lung carcinoma
5. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small cell lung cancer
6. Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients
7. Loss of function and p53 protein stabilization
8. Molecular pathology of lung neoplasia
9. Proliferation markers for neoplasms of the nervous system
10. Prognostic role of proliferating cell nuclear antigen in lung cancer: An immunohistochemical analysis
11. Prognostic role of cyclin D1 in lung cancer: Relationship to proliferating cell nuclear antigen
12. Prognostic role of cyclin D1 in non-small cell lung cancer: An immunohistochemical analysis
13. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma
14. Overexpression of cyclin D1 in rat esophageal carcinogenesis model
15. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data
16. Non-small cell lung carcinoma
17. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
18. Common neoplasms
19. Mdm2 promotes the rapid degradation of p53
20. Bcl-2 oncoprotein in surgically resected non-small cell lung cancer: Possibly favorable prognostic factor in association with low incidence of distant metastasis
21. Clinicopathological study on primary lung cancer - Immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis
22. Cyclin D1 over-expression related to retinoblastoma protein expression as a prognostic marker in human esophageal squamous cell carcinoma
23. Cell-cycle control and its watchman
24. Evaluation of the prognostic significance of P53 mutation in patients with non-small cell lung cancer
25. PCNA: Structure, function and interactions
26. Regulation of p53 stability by Mdm2
27. Expression of bcl-2 protein in non-small cell lung cancer: Correlation with clinicopathology and patient survival
28. Bcl-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in Bcl-2-cell neoplasms carrying the t (11; 14) translocation
29. Cyclin D1 is dispensable for G1 control in retinoblastoma-gene-deficient cells independently of cdk4 activity
30. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types
31. Cyclin D1 overexpression in non-small cell lung carcinoma: Correlation with Ki-67 labelling index and poor cytoplasmatic differentiation
32. Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer
33. Cancer of the lung: Molecular biology of lung cancer
34. A new international staging system for lung cancer
35. Induction of apoptosis in human lung cancer cells after wild type p53 activation by metoxyestradiol
36. Epidemiological research and survey of primary lung cancer
37. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers
38. Molecular biology of cancer: Oncogene
39. Immunohistochemical detection of p53 protein and prognosis of surgically resected non-small-cell lung cancer
40. Why is p53 protein stabilized in neoplasia? Some answers but many more questions?
41. Mammalian G1 cyclins
42. Cancer cell cycles
43. Bcl-2 protein and prognosis in patients with potentially curable non-small-cell lung cancer
44. Wild type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions
45. Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: Potential synergistic effects on prognosis
46. Atlas of cancer mortality in central Europe